Nerea Ancizar-Lizarraga

Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

J. Mar, A. Plazaola, O. Ibarrondo, 2018, ClinicoEconomics and outcomes research : CEOR.